Videos
Dr. Brian G.M. Durie continues his segment on COVID-19 frequently asked questions. In this episode, he discusses if multiple myeloma patients still need to wear masks.
The BOTTOM LINE:
It is important to continue wearing masks. For additional protection, consider…
Audio
The “A Day in the Life” podcast from the International Myeloma Foundation features messages of hope and resilience for myeloma patients, caregivers, and their loved ones. This episode features an interview with seven-year myeloma survivor Tiffany Williams, who is a nurse practitioner, a mother, a…
Videos
2020 Marks the International Myeloma Foundation's (IMF) 30th Anniversary
The IMF celebrates 30 years of scientific achievement with multiple myeloma patient care at the heart of it all.
From what started in a garage with a borrowed typewriter, a lawn chair, and lots of hope, The IMF is now…
Event
Join this all virtual meeting to get the latest updates from myeloma experts.
This RCW will highlight key topics of greatest current interest in the myeloma field. We are also including Question and Answer time with the panel of experts. We are excited to bring this important unique…
News Article
This year, the International Myeloma Foundation (IMF) has received the highest 4-star rating for the 16th time from Charity Navigator, the largest independent charity evaluator in the U.S. This year’s 4-star rating marks a fourth-consecutive year of this highest scoring for the IMF.
Michael…
Event
This RCW will highlight key topics of greatest current interest in the myeloma field. We are also including Question and Answer time with the panel of experts. We are excited to bring this important unique event to multiple myeloma patients and caregivers throughout the Southwestern USA region.
Do myeloma patients who are responding well to their treatment need to track potential bone disease?
Videos
In this episode, Dr. Brian G.M. Durie discusses the importance of routine bone testing for patients with multiple myeloma. The BOTTOM LINE:Myeloma patients should continue to monitor their bone health. Talk to your doctor about scheduling routine follow-up tests to detect…
Page
Seeking inspiration and news all in one place? The IMF blog contributors range from IMF Executive staff to newly diagnosed patients, long-term myeloma survivors, and caregivers. From the IMF Executive Staff and Editorial Team, check out the "Week in Review" blogs.
News Article
The landmark IMWG paper, published in Blood Cancer Journal, identifies patients with high-risk smoldering multiple myeloma who are candidates for early therapy and clinical trials.
LOS ANGELES, CA., October 27, 2020—The International Myeloma Working Group, a body of the…
News Article
INTERNATIONAL MYELOMA FOUNDATION 14TH ANNUAL COMEDY CELEBRATION GOES VIRTUAL IN 2020, FEATURING “EVERYBODY LOVES RAYMOND” CAST REUNION
HOSTED BY RAY ROMANO ON OCTOBER 23 AT 9 PM EST
Cast will recreate memorable scenes from classic sitcom and share stories of beloved co-stars, Peter…
Videos
In this episode, Dr. Brian G.M. Durie continues his coronavirus updates and gives his take on what myeloma patients can expect in the next few months.
The BOTTOM LINE:
Continue practicing coronavirus safety measures. Continue physical distancing, but make…
Videos
click on the image above to view the video
Multiple Myeloma Workshop Focusing on Communities in the Southern United States
What Is Included in This Virtual Myeloma Workshop?
This IMF Virtual …
Videos
(click on the image above to view the replay)(View the slides by clicking the image above.Click on the rectangle icon on the bottom right to view fullscreen.)Listen to a replay of the IMF Patient & Family Webinar. This free two-hour webinar features a panel discussion…
Event
Join us on Friday, October 23, 2020, at 6 p.m. PT / 9 p.m. ET for an exclusive Virtual Table Read Reviving the Classic Sitcom “Everybody Loves Raymond.” Actor and comedian Ray Romano returns to host and will be joined by his former fellow cast members Patricia Heaton, Brad Garrett, Monica Horan,…
Event
Join this all virtual meeting to get the latest updates from myeloma experts.
This RCW will highlight key topics of greatest current interest in the myeloma field. We are also including Question and Answer time with the panel of experts.
Page
Susie Durie founded the IMF in 1990 with her late husband, Brian Novis, and Brian G.M. Durie. M.D., to advance myeloma research and to develop and implement patient and physician educational programs in myeloma. In 1992, she was elected Executive Director of the IMF and today holds the title of…
Author
Susie Novis Durie founded the IMF in 1990 with her late husband, Brian Novis, and Brian G.M. Durie. M.D., as a means to advance myeloma research and to develop and implement patient and physician educational programs in myeloma.
In 1992, Novis Durie was elected Executive Director of the IMF.…
IMF Person
Roswell Park Comprehensive Cancer Center
New York, NY
USA
*German certified
Page
Join this all virtual meeting to get the latest updates from myeloma experts.
This RCW will highlight key topics of greatest current interest in the myeloma field. We are also including Question and Answer time with the panel of experts. We are excited to bring this important unique…
Videos
In this COVID-19 FAQ episode, Dr. Brian G.M. Durie discusses the current healthy and safety recommendations and how multiple myeloma patients can reduce their risk of coronavirus exposure.
The BOTTOM LINE:
Continue to practice strict safety guidelines. Wear a mask when…
News Article
August 26, 2020
The International Myeloma Foundation (IMF), the first and largest foundation focusing specifically on multiple myeloma, is pleased to announce the recipients of the 2020 International Myeloma Working…
Audio
The “A Day in the Life” podcast from the International Myeloma Foundation features messages of hope and resilience for myeloma patients, caregivers, and their loved ones. This episode features an interview with seven-year multiple myeloma survivor Tim Gavallas. Tim is a police officer in Watertown…
Event
Time: 8 a.m. – 9 a.m. (PST) / 18:00 - 19:00 (MSK)
Topic: Global Approaches in Multiple Myeloma
This program will be moderated by Professor Mustafa Çetiner, MD.
The panel includes the following presenters and topics:
Maxim Solovyev, PhD, Head of…
News Article
August 20, 2020
Today, the U.S. Food and Drug Administration (FDA) “approved the expansion of Kyprolis® (carfilzomib) U.S. prescribing information to include its use in combination with Darzalex® (daratumumab) plus dexamethasone (DKd) in two dosing regimens — once weekly and…
Videos
In this COVID-19 FAQ episode, Dr. Brian G.M. Durie discusses what options multiple myeloma patients have when scheduling follow-up appointments during the ongoing pandemic.
The BOTTOM LINE:
Use telemedicine for follow-up visits when possible. If an in-person follow-up…
Videos
click on the image above to view the replayDOWNLOAD SLIDESThis FREE two-hour webinar features a panel discussion about the latest…
Videos
In this COVID-19 FAQ episode, Dr. Brian G.M. Durie discusses how myeloma patients can safely "bubble" during the pandemic
The BOTTOM LINE:
A bubble is a small and exclusive social group of family or friends. Exclude those who may have had exposure to COVID-19.…
Page
In the last few weeks, President Trump has signed several executive orders that may have an impact on myeloma patients if the orders survive legal scrutiny.
For some context in understating these orders, it is important to know that executive orders are mandates or directives for executive…
Event
You can help fund $1,000,000.00 in donations for Brian Novis Research Grant Awards given by the International Myeloma Foundation. The beauty of this is that this can be accomplished without you or anyone you have help you with this, taking even one cent out of your pockets or participating in…
News Article
After the recent FDA Oncologic Drugs Advisory Committee (ODAC) Hearing’s 12-0 vote recommending approval of belantamab mafodotin, it was expected that the FDA would quickly follow suit and proceed with accelerated approval which happened today (See press…
Videos
Continuing his COVID-19 FAQ series, Dr. Brian G.M. Durie discusses if it is safe for myeloma patients to go in to the dentist for any routine dental care while the coronavirus pandemic remains a concern.
BOTTOM LINE:
It is safe for myeloma patients to visit the dentist.…
News Article
The IMF Advocacy team often talks about the Congressionally Directed Medical Research Programs (CDMRP), asking for patients to serve as consumer reviewers with the CDMRP’s Peer Reviewed Cancer Research Program (PRCRP) and updating readers on the appropriations progress of CDMRP/PRCRP,…
Audio
The “A Day in the Life” podcast from the International Myeloma Foundation (IMF) features messages of hope and resilience for myeloma patients, caregivers, and their loved ones.
We recorded the following interview with Chrissy Degennaro in July 2020.
In Memoriam: The IMF was…
Videos
Question: COVID-19 FAQ #18: Is Ninlaro® a safe treatment alternative for myeloma patients during the pandemic?
Continuing his COVID-19 FAQ series, Dr. Brian G.M. Durie discusses if myeloma patients should consider switching to an orally administered treatment…
Page
As a global organization, the IMF’s focus has never been singular. While patient-focus is at the center of all we do, recognizing and supporting leading myeloma researchers upholds our mission of Improving Lives, Finding a Cure. Explore this section to learn about IMF Research Awards.
Page
The treatment and management of multiple myeloma requires the dedication of multiple myeloma doctors, nurses, and other healthcare professionals.
The IMF works to support supplemental educational efforts for these multiple myeloma experts by providing access to the latest myeloma research…
Page
According to the National Institutes of Health, CME or Continuing Medical Education, consists of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the…
Page
Multiple myeloma testing, staging, and prognosis can be a complex process involving various procedures. Learn more about the various kinds of tests, staging, and how health professionals determine a prognosis. Testing Health professionals use a range of tests throughout the course…
Videos
Continuing his COVID-19 FAQ series, Dr. Brian G.M. Durie discusses the risk asymptomatic carriers pose to myeloma patients and what patients can do to minimize the risk of infection.
BOTTOM LINE:
Asymptomatic carriers present a high risk. Continue to practice physical…
News Article
An independent panel to the U.S. Food and Drug Administration on Tuesday voted in favor of approving GlaxoSmithKline’s experimental treatment for a common form of blood cancer, saying the benefits of the treatment outweigh the risks.…
Videos
Question: Is it safe for myeloma patients to travel by airplane?
Continuing his COVID-19 FAQ series, Dr. Brian G.M. Durie discusses if it is safe for myeloma patients to travel by airplane while the COVID-19 infection continues to remain a concern.
BOTTOM LINE…
Page
What Is Xpovio (Selinexor)?XPOVIO® (selinexor) is the first and only medication in the drug class known as selective inhibitor of nuclear export (SINE) that has been approved to treat myeloma by the FDA. Xpovio works by preventing myeloma cells from expelling tumor suppressor proteins that help…
Page
What Is Sarclisa?
SARCLISA® is a monoclonal antibody that binds to the CD38 (cluster of differentiation 38) receptor on the surface of myeloma cells. The CD systemis designed to classify more than 200 proteins that can be expressed on (stick out of) the surface of a cell.
CD38 is…
Videos
Question: What are the results from the ENDURANCE trial that compares KRd to VRd in newly diagnosed myeloma patients?
In this video, Dr Brian Durie discusses the results of the ENDURANCE trial presented at the 2020 ASCO meeting.
…
Videos
Question: COVID-19 FAQ #15: Is dexamethasone helpful against the COVID-19 infection?
Continuing his COVID-19 FAQ series, Dr. Brian Durie discusses the RECOVERY trial which evaluates the benefit of the steroid dexamethasone when treating patients with COVID-19.
…